King & Wood Mallesons advised Kither Biotech, while McDermott Will & Emery advised the investors on the deal.Kither Biotech, an Italian biopharmaceutical company developing novel therapies…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
